James Veal is the founder of 858 Therapeutics. 858 Therapeutics has raised $110M in total funding. Latest round: Series A. Based in San Diego, United States.
Dr. James Veal is the Chief Scientific Officer (CSO) and a co-founder of 858 Therapeutics, a San Diego-based biotechnology company. He joined the company after it operated in stealth mode for over two years, coinciding with its public launch and Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library